• Asian Pacific Journal of Cancer Prevention
• /
• 제17권4호
• /
• pp.1661-1675
• /
• 2016

Objectives: Can addition of neurokinin-1 receptor antagonists (NK1-RAs) be considered as an ideal strategy for the prevention of chemotherapy-induced nausea and vomiting (CINV)? Researchers differ on this question. Materials and Methods: Electronic databases were searched for randomized control trials (RCTs) that evaluated the effectiveness and safety of NK1-RAs in preventing CINV. The primary end point was complete response (CR) in the acute, delayed, and overall phases after chemotherapy. Subgroup analyses evaluated the types of NK1-RAs, routines of administration, types of malignancies, regimens used in combination with NK1-RAs, and age of patients included in the studies. The incidences of different types of adverse events were also extracted to estimate the safety of NK1-RAs. Results: A total of 38 RCTs involving 13,923 patients were identified. The CR rate of patients receiving NK-RAs was significantly higher than patients in the control groups during overall phase (70.8% vs 56.0%, P<0.001), acute phase (85.1% vs 79.6%, P<0.001), and delayed phase (71.4% vs 58.2%, P<0.001). There were three studies including patients of children or adolescents, the CR rate was also significantly higher in the treatment group (overall phase: OR=2.807, P<0.001; acute phase: OR=2.863, P =0.012; delayed phase: OR=2.417, P<0.001). For all the other outcomes, patients in the NK1-RAs groups showed improvements compared to the control groups (incidence of nausea: 45.2% vs 45.9%, P<0.001; occurrence of vomiting: 22.6% vs 38.9%, P<0.001; usage of rescue drugs: 23.5% vs 34.1%, P<0.001). The pooled side effects from NK1-RAs did not significantly differ from previous reports and the toxicity rates in patients less than eighteen years old also did not diff between the two groups (P=0.497). However, we found that constipation and insomnia were more common in the patients of control groups, whereas diarrhea and hiccups were more frequently detected in patients receiving NK1-RAs. Conclusions: NK1-RAs improved the CR rate of CINV. They are effective for both adults and children. The use of NK1-RAs might be associated with the appearance of diarrhea and hiccups, while decreasing the possibility of constipation and insomnia.

• 대한한방내과학회지
• /
• 제42권4호
• /
• pp.488-509
• /
• 2021

Purpose: Functional dyspepsia (FD) is a chronic syndrome accompanied by repetitive digestive symptoms that appear in the upper gastrointestinal tract and are not caused by specific diseases. Psychological symptoms like anxiety, depression, insomnia, and somatization are frequently observed in FD. The purpose of this study was to review the effect of herbal medicine on the psychological symptoms that accompany FD. Methods: Database search (PubMed, EMBASE, KISS, Kmbase, KoreanMed, NDSL, OASIS, CNKI) was performed on February 24, 2021; a total of 1825 studies were searched. After the screening, 22 studies were included. Results: The studies were assessed by Cochrane RoB 2 and sorted into a table according to psychological symptoms. Meta-analysis was performed to estimate the effect of herbal medicine. Twenty of the twenty-two studies reported that herbal medicine was significantly more effective than the control group. Only three of the studies did not have a high risk of bias. Conclusion: Herbal medicine was significantly effective with or without Western medicine and had fewer adverse effects. Severe adverse effect was not reported. Psychological symptoms in FD affect onset and duration of FD, and some FD patients want to be treated for their anxiety before other symptoms. Reliable information about treatment for the psychological symptoms of FD is lacking. We reviewed the effect of herbal medicine treatment in this study, the results of which could be selected for primary or secondary treatment for FD.

• 수면정신생리
• /
• 제8권1호
• /
• pp.37-44
• /
• 2001

목 적 : 최근 수면장애에 대한 3가지 진단 분류 체계가 발달하였다. 즉 국제 수면장애 분류(the International Classification of Sleep Disorder, ICSD), 정신장애의 진단 및 통계 편람 제 4 판(the Diagnostic and Statistical Manual, 4th edition, DSM-IV) 그리고 국제 질병 분류 제 10 판(the International Classification of Diseases, 10th edition, ICD-10)이다. 국내에는 이들 진단 체계간의 비교에 대한 자료가 거의 없다. 본 저자들은 수면 문제로 정신과에 의뢰된 환자를 DSM-IV와 ICSD에 따라 진단하고 이를 비교하여 그 차이를 비교하고자 하였다. 방 법 : 고려대학부속 안암병원에 입원 환자 중 수면장애로 정신과에 의뢰된 284명의 환자를 대상으로 ICSD를 숙수면장애에 대한 ICSD와 DSM-IV 진단 비교 44지하지 않은 정신과 전공의와 ICSD를 숙지한 정신과 전공의가 비구조화된 면담을 시행하고, DSM-IV와 ICSD의 진단 기준에 따라 임상적 진단을 하여 그 차이를 비교하였다. 결 과 : DSM-IV 진단 분류에는 "기타 정신장애 관련 불면증"(전체의 61.1%)과 "일반적인 의학적 상태로 인한 섬망"(26.8%)이 빈도가 가장 높았다. ICSD에서는 "신경과적 장애가 동반된 수면장애" (38.4%)와 "정신과적 장애가 동반된 수면장애" (33.1%)의 빈도가 가장 높았다. DSM-IV와 ICSD의 비교에서, DSM-IV에서 신체적 질환이나 정신과적 질환과 무관한 수면장애로 진단된 환자군은 대부분 ICSD와 일치하였고, 이들 중 DSM-IV의 "일차적 불면증"은 ICSD의 "정신생리적 불면증"과 "부적수면위생"으로 구분되었다. DSM-IV에서 신체적 질환이나 정신과적 질환에 의한 수면장애를 가진 269명 중 62명(23%)이 ICSD와 불일치하였고 이들 중 대부분이 ICSD에서 신체적 질환이나 정신과적 질환과 무관한 수면장애인 "부적수면위생", "환경성 수면장애", "적응성 수면장애" 그리고 "수면결핍장애" 등이었다. 결 론 : 본 연구에서 DSM-IV와 ICSD의 진단 체계가 많은 부분 일치하였으나, 간과할 수 없는 차이를 가지고 있음을 확인하였다. 이 차이는 수면장애에 대한 임상의의 태도를 반영한다. 즉, 수면장애에 대한 개념화와 원인에 대한 임상의의 이해 정도에 따라, 수면장애를 진단하지 못하거나 적절한 치료를 할 수 없다. 따라서 본 연구에서 나타난 DSM-IV와 ICSD에 대한 임상의의 이해 정도는 중요하다고 할 수 있다.

• 수면정신생리
• /
• 제14권1호
• /
• pp.20-25
• /
• 2007

목 적：본 연구는 양측 손목 액티그라프(wrist actigraphy：WATG) 간의 WATG 지수와 각각의 WATG와 야간수면다원검사(nocturnal polysomnography：NPSG) 간의 수면지수를 비교 분석하여 차이와 일치도를 보고자 하였다. 방 법：우수 우성인 22명(평균연령 $43.9{\pm}13.3$세, 남：여=14：8)의 치료받지 않은 일차성 수면장애를 가진 환자(primary insomnia=8, simple snorer=2, obstructive sleep apnea=12)를 대상으로 선정하였다. 대상자들은 양측 손목에 WATG를 착용한 채 1일밤 NPSG를 시행하였다. 양측 WATG 지수간을 상관관계 및 차이를 분석하였다. 각 WATG와 NPSG 간의 수면기간시간, 총수면시간, 수면 잠복기, 수면효율 및 각성 시간에 대하여 상관관계 및 차이를 분석하였다. 결 과：양측 WATG 지수간의 상관관계 분석에서 수면잠복기와 수면분절지수에서 유의한 상관관계가 없었고, 그외의 다른 수면지수들에서는 통계적으로 유의한 수준으로 양의 상관관계가 있었다(p<0.05). 양측 WATG의 수면지수 간의 양적 비교에서는 통계적으로 유의한 차이가 없었다. 각 WATG와 NPSG 수면지수 간의 상관관계 분석에서 양측 WATG 수면기간시간, 좌측 WATG의 수면잠복기 그리고 우측 WATG의 총수면시간이 유의한 양의 상관관계를 보였고, 우측 WATG의 수면효율은 유의한 음의 상관관계를 보였다. 각 WATG와 NPSG 수면지수 간의 양적 비교에서 NPSG에 비해 WATG에서 양측의 수면기간시간(p<0.001, p<0.001)과 우측의 각성시간(p<0.05)은 감소되었으며, 좌측의 수면잠복기(p<0.001)와 우측의 총수면시간과 수면효율(p<0.05, p<0.05)은 증가되었다. 결 론：양측 WATG 수면지수 간의 상관관계에서 수면잠복기와 수면분절지수의 불일치는 각성시간 동안 WATG의 활동도가 양측간에 차별적으로 발생할 수 있다는 것을 의미한다. NPSG와 각 WATG의 수면지수 상관관계에서 보여주고 있는 불일치는 일일밤 수면분석을 위해 NPSG를 대신하여 WATG를 이용하는 것에 제한된 점이 있다는 것을 시사한다.

• 대한한방내과학회지
• /
• 제21권3호
• /
• pp.369-376
• /
• 2000

Purpose : Cerebrovascular disease is the most frequent cause of death in Korea and it remains severe disabilities disturbing normal life, According to the previous studies, mortality of the stroke in the first one week is up to the 20% and 95% of stroke patients in the acute stage are accompanied by more than one complications. These complications affect not only the acute stage mortality but also the late stage rehabilitations. In Korea the oriental medicine is preformed in the treatment of stroke. Therefore it is important to recognize thoroughly the complications in the acute stage of stroke and to prevent them. But studies about complications of acute stage stroke is rarely presented in the fields of oriental medicine. So this study is prepared for investigating the characteristics and frequency of complications in the acute stage of stroke. And we are to assess the importance of theses acute complications by systemic reviewing the previous studies. Methods : Fifty one patients are included who had been admitted to ICU(intensive care unit) of Chenju Hospital of Wonkwang Oriental Medicine. Twenty nine patients are diagnosed as ischemic stroke and twenty one patients are diagnosed hemorrhagic stroke. Medical and neurological complications were investigated retrospectively based on medical notes excluding primary symptoms of stroke Le. motor weakness, sensory disturbance and speech disorder. And risk factors of stroke such as D.M. or hypertension are excluded. Results : Medical complications are more frequent than neurological ones. Most frequent medical complication is dysuria(61%) and constipation(45%), fever(30%) and aspiration pneumonia(22%) are followed in order of frequency. In Neurological complication dysphagia(56%), the exacerbation of infarction due to increased intracranial pressure(24%), irritability or insomnia(21%) is most frequently complicated in order of frequency. Conclusions : These complications are mostly caused by bed rest state in acute stage stroke. It is supposed that more aggressive management can prevent theses ones. And it is possible to improve the medical and neurological conditions by sticking theses study results.

• 대한암한의학회지
• /
• 제22권1호
• /
• pp.23-35
• /
• 2017

Backgrounds: The demand of complementary and alternative medicine (CAM) including Korean Medicine (KM) is increasing worldwide. But cancer patients (CP) still have a difficulty in gathering CAM information or communicating with their doctors, and clinical status in cancer care is unclear in the field of KM in Korea especially. The aim of this study is to examine clinical status of KM for cancer symptom care by KM doctors in medical service institutions. Methods: Total forty nine KM doctors completed the site survey questionnaire. The questionnaire items were to list chief symptom complaints of CP treated with KM and effective KM therapies. Results: The majority of the respondents were general physicians without KM specialist board (67.4%) who have 10-20 years clinical experience with CP (55.1%). Primary cancer lesion, diagnostic status, and treatment period were not different in KM clinical service institutions. In chief symptom complaints of CP treated with KM, gastrointestinal (32.9%), musculoskeletal (19.9%), circulatory & respiratory (16.2%), psychiatric (14.1%), urinary (5.8%) symptoms were in turn. In effective KM therapies assessed by KM doctors, xerostomia (45.7%) and cancer-related fatigue (44.8%) were more effective with herbal treatments. Peripheral neuropathy (43.4%), depression, insomnia (38.2%), and cancer pain (31.9%) were preferred to treat using acupuncture. Conclusion: The CP treated with KM used evenly KM medical service institutions regardless of hospital size, and there will be further survey for CP treated KM in the future.

• 동의신경정신과학회지
• /
• 제31권2호
• /
• pp.63-76
• /
• 2020

Objectives: The purpose of this study was to verify the clinical effects of herbal medicines on patients with depressive disorder. Methods: A prospective observational study on patients with depressive disorder was conducted. The patients were treated with herbal medicines for eight weeks. The Korean Hamilton Depression Rating Scale (K-HDRS) was evaluated as the primary outcome and the Korean Beck's Depression Inventory (K-BDI), Instrument on Pattern Identification for Depression, Korean Symptom Checklist-95 (KSCL-95), Insomnia Severity Index (ISI), Korean State-Trait Anxiety Inventory (STAI-K), Korean State-Trait Anger Expression Inventory (STAXI-K), EuroQol five-dimensional Questionnaire (EQ-5D), Minnesota Multiphasic Personality Inventory-2 (MMPI-2), Heart Rate Variability (HRV) were measured as the secondary outcome. Adverse events were assessed for safety. Results: A total of 35 participants were observed for 12 weeks. The K-HDRS improved significantly in four, eight, and 12 weeks and the K-BDI showed significant differences in four, and eight weeks. There were no significant improvements in other evaluation scales. Gyejibongnyeong-hwan was the most frequently and continuously prescribed, showing significant improvements of K-HDRS after eight weeks of treatment. Conclusions: In our observational study, herbal medicine was effective for relieving the depression of patients with depressive disorder and Gyejibongnyeong-hwan showed the most significant effectiveness.

• 한국간호교육학회지
• /
• 제10권1호
• /
• pp.149-160
• /
• 2004

The primary purpose of this study was to describe psychological aspects of menopausal women who have experiences on alternative therapies, such as pomegranate tree fluid, life pack, evening primerose, zacro syrup, zacro pill, multi-vitamin, oriental medicine instead of estrogen. In order to have insights on the participants behaviors, this qualitative research was conducted. The participants in this study were six women who have been taking at least one of the alternative therapies to relieve the menopausal symptom. Data had been collected from November 2002 to May 2003. The interview questions were about motivations to seek the alternative therapy, menopausal symptoms, feelings or positive effects after the treatment. The interviews were recorded and transcribed into written documents. The method described by Giorgi was utilized for data analysis. The study results were as follows : 1. The participants sought the alternative therapy based on their own information or by friends' recommendations. The motivations of taking the therapy were to live younger and healthier by reliving menopausal symptoms including somatic symptoms, such as irregular menstruation, flushing sense, cold sweating, insomnia, dull headache, vagina dryness, cystitis after sexual intercourse, joint pain, nervousness, depression, skin dryness, and suppression of activity. 2. The participants expressed that they became more active and felt better with disappearing menopausal symptoms after about 2 to 3 weeks treatment. 3. The participants did not want to accept the fact that they had menopause, which caused avoidance of having medical diagnosis and medical treatment. They also did not want to let their spouses know about their symptoms. 4. The major reason of taking the alternative therapy was to avoid the side effects of estrogen therapy in spite of high costs of the alternative way. 5. The participants suggested that menopausal women needed to be educated about physical and psychological symptoms of menopause. They also needed to be informed about how to manage it. In conclusion, accurate information about foods and drugs utilized for the alternative therapy was needed. Medically proved methods to recognize positive effects and side effects were also necessary. These goals could be achieved by continuous medical observations and further research.

• 동의신경정신과학회지
• /
• 제33권2호
• /
• pp.157-180
• /
• 2022

Objectives: To perform a systematic review of placenta pharmacopuncture for treating neuropsychiatric diseases, focusing on its efficacy and the safety so that evidence on its clinical use could be obtained, thus contributing to further studies. Methods: Through Korean, English, and Chinese databases (OASIS, Korean TK, KISS, RISS, ScienceON, Pubmed, Cochrane, EMBASE, CINAHL, AMED, CNKI, and Wanfang), combinations of keywords (placenta, pharmacopuncture, etc.) were used to select clinical studies published until January 2021 about placenta pharmacopuncture for neuropsychiatric diseases. Interventions included combined treatments. Study design included cases studies, series, and clinical trials. Cohort studies, literature reviews, in vitro and animal experiments were excluded. The primary outcomes involved measurements of symptoms, Visual Analogue Scale, or questionnaires. Data extracted from databases were imported to Endnote X7 to remove duplicates. The quality of the literature was assessed based on CAse REports Guidelines and Cochrane's Risk of Bias (ROB). Results: Twenty-one studies were selected, including ten case reports, three case series, two one-armed clinical trials, one non-randomized clinical trial, and five randomized clinical trials. There were six studies on sleep disorders, five studies on stroke sequela, two on mood disorders, two on enuresis, two on Guillain-Barré syndrome, two on multiple sclerosis, one on neurocognitive disorder, and one on vertigo. The most frequent combined treatment was acupuncture in both the experimental group (n=10) and the control group (n=3). Acupoints were ST36, SP6, BL23, CV4, GB20, GV20, N-HN54, and so on. All studies reported improvement of symptoms. The quality of case studies was relatively high. Assessment of ROBs resulted in low risks. Conclusions: Placenta pharmacopuncture is effective for neuropsychiatric diseases such as sleep disorders, mood disorders, enuresis, and neurocognitive disorders. Regarding insomnia, several studies have reported significant improvements with placenta pharmacopuncture. There was no adverse event associated with placenta pharmacopuncture.

• 동의신경정신과학회지
• /
• 제33권4호
• /
• pp.389-400
• /
• 2022

Objectives: Depression is a highly prevalent disease, and the market for antidepressant drugs continues to grow at a steady rate. Although current antidepressants are reported to be effective, because of their low remission rate and side effects, new antidepressants are needed. The use of Banhahubak-tang (BHT) to treat the symptoms of depression is supported by experimental evidence. The proposed study will evaluate the efficacy and safety of BHT in treating depression. Methods: A randomized, waitlist-controlled, parallel clinical trial will be conducted to assess the efficacy of BHT in depression. A total of 84 participants with depression will be randomized into the intervention group or waitlist-control group at a 1:1 ratio. Patients in the intervention group will be administered BHT three times a day for four weeks and followed up for four more weeks after therapy completion. Patients in the waitlist-control group will undergo the same intervention and follow-up after a four-week waiting period. The primary outcome is change in the Korean version of the Hamilton Depression Rating Scale (K-HDRS) scores for major depressive disorders after four weeks. The secondary outcomes include scores on the K-HDRS, Korean Symptom Check List 95 (KSCL-95), Insomnia Severity Index (ISI), State-Trait Anxiety Inventory-Korean version (STAI-K), State-Trait Anger Expression Inventory-Korean version (STAXI-K), and the Instrument on Pattern Identifications for Depression and EuroQol-5 Dimension (EQ-5D). Conclusions: This trial will provide high-quality clinical evidence of the efficacy and safety of BHT in the management of depression.